Table 2. Binary and multivariable logistic regression of variables associated with physical need domain among oncology patients at DRH, Dessie, : Ethiopia, 2020.
| Variables | Physical need domain | ||||
|---|---|---|---|---|---|
| No need | Some need | COR (CI) | AOR (CI) | p value | |
| Age | 1.04 (1.01–1.05) | 1.03 (1.01–1.06) | <0.001a | ||
| Occupational status | |||||
| Employed | 15 (14.6) | 39 (12.9) | 1 | 1 | |
| Paid work | 32 (31.1) | 87 (28.8) | 1.04 (0.51–2.15) | 1.33 (0.56–3.18) | 0.903 |
| Jobless | 55 (53.4) | 94 (54.0) | 1.14 (0.58-2.22) | 1.67 (0.66–4.3) | 0.701 |
| Retired | 1 (1.0) | 13 (4.3) | 5.0 (0.6–41.63) | 2.62 (0.22–30.9) | 0.137 |
| Marital status | |||||
| Single | 12 (11.7) | 29 (9.6) | 1 | 1 | |
| Married | 76 (73.8) | 192 (63.6) | 1.04 (0.51–15) | 0.75 (0.30–1.87) | 0.904 |
| Divorced | 4 (3.9) | 30 (9.9) | 3.1 (0.89–10.7) | 1.75 (0.41–7.51) | 0.074 |
| Widowed | 11 (10.7) | 51 (16.9) | 1.92 (0.75–4.89) | 0.92 (0.25–3.34) | 0.173 |
| Health insurance | |||||
| Yes | 69 (67.0) | 164 (54.3) | 1 | 1 | |
| No | 34 (33.0) | 138 (45.7) | 0.58 (0.36–0.93) | 0.75 (0.43–1.34) | 0.095 |
| Monthly household income | |||||
| 0–1,500 | 50 (48.5) | 105 (34.8) | 1 | 1 | |
| 1,501–2,000 | 22 (21.4) | 69 (22.8) | 1.49 (0.83–2.68) | 1.82 (0.85–3.9) | 0.18 |
| 2,001–2,700 | 9 (8.7) | 51 (16.9) | 2.7 (1.23–5.91) | 2.95 (1.19–7.3) | 0.013a |
| >2,700 | 22 (21.4) | 77 (25.5) | 1.66 (0.93–2.98) | 1.92 (0.77–4.8) | 0.085 |
| Informational status | - | 1.18 (1.03–1.36) | 1.17 (0.98–1.38) | 0.074 | |
| Cancer site | |||||
| Breast | 52 (50.5) | 86 (28.5) | 1 | 1 | |
| Colon | 10 (9.7) | 29 (9.6) | 1.75 (0.79–3.89) | 1.23 (0.49–3.06) | 0.167 |
| Prostate | 3 (2.9) | 33 (10.9) | 6.6 (1.94–22.02) | 9.1 (2.34–35.74) | 0.003a |
| Lung | 2 (1.9) | 35 (11.6) | 10.58 (2.44–45.8) | 8.15 (1.76–37.6) | 0.002a |
| Skin | 7 (6.8) | 23 (7.6) | 1.98 (0.79–4.95) | 1.67 (0.6–4.63) | 0.141 |
| Cervical | 18 (17.5) | 65 (21.5) | 2.18 (1.16–4.08) | 2.23 (1.06–4.67) | 0.014a |
| Lipoma | 11 (10.7) | 31 (10.3) | 1.7 (0.79–3.67) | 1.36 (0.54–3.44) | 0.174 |
| Treatment type | |||||
| Chemotherapy | 75 (72.8) | 165 (54.6) | 1 | 1 | |
| Surgery | 9 (8.7) | 75 (24.8) | 3.7 (1.8–7.96) | 6.92 (2.95–16.2) | <0.001a |
| Analgesia | 19 (18.4) | 62 (20.8) | 1.48 (0.83–2.65) | 1.28 (0.64–2.57) | 0.184 |
| Cancer stage | |||||
| Early stage (I, II) | 38 (36.9) | 62 (20.5) | 1 | 1 | |
| Late stage (III, IV) | 65 (63.1) | 240 (79.5) | 2.2 (1.39–3.69) | 2.19 (1.18–4.06) | <0.001a |
| Recurrence | |||||
| No | 2 (1.9) | 16 (5.3) | 1 | 1 | |
| Yes | 101 (98.1) | 286 (94.7) | 0.35 (0.08–1.56) | 0.57 (0.11–2.82) | 0.171 |
| Coexisting diseases | |||||
| No | 88 (85.4) | 228 (75.5) | 1 | 1 | |
| Yes | 15 (14.6) | 74 (24.5) | 1.9(1.04–3.49) | 1.41 (0.7–2.86) | 0.088 |
COR, Crude odds ratio; AOR, Adjusted odds ratio; CI, Confidence interval
a
Statistically significant at p < 0.05